Are you aware of the federal funding program that supports the commercialization efforts of biotech innovators? The Small Business Innovation Research (SBIR) program at the National Cancer Institute (NCI) provides up to $6.4 million in funding to life science startups, with no strings attached.
As part of the NCI’s engine of innovation for advancing novel cancer-related technologies from lab to market, the SBIR Development Center funds a diverse portfolio of small businesses that are developing technologies to prevent, diagnose, and treat cancer.
To learn more, join NCI SBIR, Rutgers University, and the NSF I-Corps Hub Northeast Region for an information session during a provided luncheon from 11:00 am–12:45 pm ET on Monday, May 20, 2024 at Princeton Innovation Center BioLabs.
Following introductory presentations from cohosting organizations, NCI SBIR Program Director Sarra Djemil will provide a detailed overview on funding opportunities, commercialization resources, and application advice that biotech researchers can use to move their projects forward. This presentation is appropriate for researchers who are considering forming a small business to translate their work and bring their ideas to life. Topics to be covered include:
· New and current funding opportunities
· Application tips and suggestions
· Commercialization resources for applicants and awardees
After the presentation, attendees will have a chance to participate in a Q&A with NCI SBIR awardee Neil Goldstein and meet one-on-one in person with Program Director Sarra Djemil to discuss their cancer technology project and funding eligibility. To be considered for a one-on-one meeting, please reach out to Michelle Roemer-Schoen (michelle@biolabs.io) with a one-page technology summary or specific aims page on your technology by Monday, May 13, 2024.
For questions about this event, please email Michelle Roemer-Schoen (michelle@biolabs.io). We look forward to seeing you there!
